Platinum(IV) Complex with Adamantylamine as Nonleaving Amine Group: Synthesis, Characterization, and in Vitro Antitumor Activity against a Panel of Cisplatin-Resistant Cancer Cell Lines-Reference-Cited by-同舟云学术

Platinum(IV) Complex with Adamantylamine as Nonleaving Amine Group: Synthesis, Characterization, and in Vitro Antitumor Activity against a Panel of Cisplatin-Resistant Cancer Cell Lines

Published:2003-12-23 Issue:3 Volume:47 Page:761-763
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Žák František¹,Turánek Jaroslav¹,Kroutil Aleš¹,Sova Petr¹,Mistr Adolf¹,Poulová Anna¹,Mikolin Petr¹,Žák Zdirad¹,Kašná Andrea¹,Záluská Dana¹,Neča Jiří¹,Šindlerová Lenka¹,Kozubík Alois¹

Affiliation:

1. PLIVA-Lachema a.s., Karásek 1, 621 33 Brno, Czech Republic; Department of Immunology, Veterinary Research Institute, Hudcova 70, 621 33 Brno, Czech Republic; Department of Inorganic Chemistry, Masaryk University, Kotlářska 2, 611 37 Brno, Czech Republic; and Institute of Biophysic, The Academy of Sciences of the Czech Republic, Královopolská 135, 61265 Brno, Czech Republic

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/jm030858%2B

Reference8 articles.

1. The relationships between glutathione, glutathione-S-transferase and cytotoxicity of platinum drugs and melphalan in eight human ovarian carcinoma cell lines

Cited by 72 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Platinum-based drugs in cancer treatment: Expanding horizons and overcoming resistance;Journal of Molecular Structure;2024-04

2. Inhibition of Chk1 stimulates cytotoxic action of platinum-based drugs and TRAIL combination in human prostate cancer cells;Biological Chemistry;2024-03-08

3. Homo and heterometallic ruthenium and platinum complexes with multiple targets for therapeutic applications: a review;Reviews in Inorganic Chemistry;2023-05-12

4. Stimuli-responsive platinum and ruthenium complexes for lung cancer therapy;Frontiers in Pharmacology;2022-10-17

5. Targeting HSP90 as a Novel Therapy for Cancer: Mechanistic Insights and Translational Relevance;Cells;2022-09-06